United States Specialty PACS Market Assessment, By Component [Hardware, Software, Services], By Delivery Model [On-Premises Model, Web/Cloud-Based Model], By Type [Radiology, Cardiology, Pathology, Ophthalmology, Orthopedics, Endoscopy, Others], By End-user [Hospitals and Specialty Clinics, Ambulatory Surgical Centers (ASCS), Diagnostic Imaging Centers, Others], Opportunities and Forecast, 2018-2032F

The United States specialty PACS market is supported by the growing demand for imaging equipment, technological advancements in diagnostic imaging modalities, penetration of artificial intelligence (AI) in medical imaging, and rapidly growing telehealth market.

Home>Industry Reports>United States Specialty PACS Market Assessment, Opportunities and Forecast, 2018-2032F

United States specialty picture archiving and communication system (PACS) market is projected to witness a CAGR of 6.63% during the forecast period 2025-2032, growing from USD 1.11 billion in 2024 to USD 1.85 billion in 2032. The increasing complexity of diagnostic imaging drives the United States specialty PACS market needs in specialized departments. Rising investments in healthcare IT and demand for interoperable, AI-enhanced systems are accelerating adoption. Additionally, the growing role of personalized and precision medicine is creating a need for more accurate and specialty-specific imaging platforms.

Report Attributes

Details

Base Year

2024

Forecast Period

2025-2032

Historical Period

2018-2023

Projected Growth Rate

CAGR of 6.63% between 2025 and 2032

Revenue Forecast in 2032

USD 1.85 billion

For instance, Royal Philips, a prominent global entity in health technology, has recently declared the launch of Philips HealthSuite Imaging on Amazon Web Services (AWS). Furthermore, Philips and AWS enhanced their collaboration, focusing on the advancement of artificial intelligence in healthcare. This will involve the utilization of Foundation Models through Amazon Bedrock to expedite the creation of cloud-based generative AI applications aimed at offering clinical decision support, facilitating more precise diagnoses, and streamlining administrative processes.

Growing Utilization of Specialty Imaging Across Clinical Practices

The demand for specialty PACS is surging in the United States due to increasing imaging volumes across non-radiology departments such as cardiology, pathology, ophthalmology, and orthopedics. This shift is being driven by the growing prevalence of chronic conditions and the clinical necessity for accurate, high-resolution imaging to support timely diagnoses. Healthcare providers are focusing on enhancing workflow efficiency and improving clinical outcomes, which fuels the integration of specialty PACS systems tailored to specific departmental needs. Additionally, reimbursement frameworks in the United States are aligning more favorably toward advanced imaging procedures, further incentivizing adoption. Hospitals and diagnostic centers are transitioning from conventional PACS to modular, specialty-focused systems to reduce turnaround time, improve collaboration among care teams, and enhance diagnostic precision. This trend is particularly noticeable in large hospital networks where data centralization and interoperability are crucial. As specialty care expands, the specialty PACS market is poised for long-term growth in the United States.

Technological Advancements Drive AI Integration in Specialty PACS

Technological developments in artificial intelligence (AI), machine learning, and cloud computing are transforming the United States specialty PACS landscape. Vendors are increasingly incorporating advanced algorithms that support image analysis, pattern recognition, and clinical decision-making, especially in pathology, radiology, and cardiology. These tools assist in early disease detection, automate measurements, and reduce the diagnostic burden on clinicians. The integration of AI also enhances interoperability with hospital information systems (HIS) and electronic health records (EHR), offering seamless data access across departments. The growing availability of web/cloud-based PACS platforms supports remote diagnostics, which gained momentum post-pandemic and continues to be a preferred model for teleradiology and off-site consultations. Real-time collaboration and faster turnaround times are made possible with these digital upgrades. Companies such as IBM Watson Health and Intelerad are introducing AI-enabled PACS tools to enhance efficiency in diagnostic workflows, reduce human error, and support value-based care models in the United States healthcare ecosystem. For instance, INFINITT is set to introduce its latest Ophthalmology PACS. This web-based image management solution features an advanced HTML5 viewer, offering seamless experience with no downloads required and a server-side rendered interface. It has been specifically designed to cater to the unique requirements of professionals in ophthalmology departments, including both doctors and photographers.

Precision Medicine Initiatives Encourage Specialty PACS Adoption

The rise of precision medicine in the United States is fueling the demand for high-quality, specialty-focused imaging solutions. Tailoring treatment based on individual patient profiles requires in-depth, multi-modality imaging data and seamless data integration—an area where specialty PACS excels. These systems provide clinicians with accurate, real-time access to patient-specific imaging records, supporting more targeted diagnostic and therapeutic decisions. In cardiology, for example, specialty PACS help analyze vascular structures and support interventions like stenting or bypass procedures. Similarly, in pathology, digital PACS platforms facilitate image-based assessments crucial for oncology diagnostics. The United States healthcare system’s shift towards personalized care has led hospitals and specialty centers to invest in advanced PACS solutions that align with molecular diagnostics, genetic screening, and AI-powered analysis. By enabling precise imaging correlation with genetic and clinical data, specialty PACS is becoming a cornerstone technology in the precision medicine ecosystem—enhancing outcomes and enabling more proactive, individualized patient care strategies.

For instance, in December 2024, during the 2024 Annual Meeting of the Radiological Society of North America (RSNA), scheduled from December 1-4 in Chicago, GE HealthCare showcased over 40 innovations, featuring several significant artificial intelligence (AI)-driven technologies aimed at enhancing patient care and improving operational efficiencies. The products offered by GE HealthCare are crafted to boost efficiency and facilitate seamless integration of data, thereby supporting precision care across various treatment pathways. These advancements reflect the company's comprehensive AI and digital strategy, which emphasizes the incorporation of AI into medical devices, the development of AI applications that improve decision-making throughout the care continuum and across different disease states, and the utilization of AI to foster better health outcomes.

Download Free Sample Report

Future Market Scenario (2025-2032F)

The United States specialty PACS market is poised for significant growth in the coming years due to increasing digitization of medical imaging and rising demand for department-specific imaging solutions. As healthcare providers move toward integrated and value-based care, there is a growing need for high-performance systems tailored to specialties such as cardiology, pathology, orthopedics, and ophthalmology. The expansion of precision medicine, adoption of AI-integrated diagnostics, and cloud-based storage solutions are further fueling demand. Additionally, increased investment in healthcare IT infrastructure and the rising prevalence of chronic diseases are pushing hospitals and diagnostic centers to adopt specialized imaging platforms. The market is expected to witness strong adoption across both large healthcare systems and smaller specialty clinics.

Report Scope

“United States Specialty PACS Market Assessment, Opportunities and Forecast, 2018-2032F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the United States specialty PACS market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2025 and 2032. Additionally, the report profiles the leading players in the industry, mentioning their respective market share, business models, competitive intelligence, etc.

Report Attribute

Details

Segments Covered

Component, Delivery Model, Type, End-user

Regions Covered

Northeast, Midwest, West, South

Key Companies Profiled

IBM Corporation, Mckesson Corporation, Agfa US Corp., Onex Corporation (Carestream Health, Inc.), Novarad Corporation, Intelerad Medical Systems Incorporated, INFINITT Healthcare Co., Ltd., Sectra Medical, Inc., Topcon Corporation, Meddiff Technologies Private Limited

Customization Scope

15% free report customization with purchase

Pricing and Purchase Options

Avail the customized purchase options to fulfill your precise research needs

Delivery Format

PDF and Excel through email (subject to the license purchased)

In the report, the United States specialty PACS market has been segmented into the following categories: 

  • By Component
    • Hardware
    • Software
    • Services
  • By Delivery Model
    • On-premises Model
    • Web/Cloud-Based Model
  • By Type
    • Radiology
    • Cardiology
    • Pathology
    • Ophthalmology
    • Orthopedics
    • Endoscopy
    • Others
  • By End-user
    • Hospitals and Specialty Clinics
    • Ambulatory Surgical Centers (ASCS)
    • Diagnostic Imaging Centers
    • Others
  • By Region
    • Northeast
    • Midwest
    • West
    • South

Key Players Landscape and Outlook

The key players in the market are significantly investing in the development of specialty PACS and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.

In January 2025, Sutter Health and GE HealthCare announced a seven-year strategic partnership, referred to as a Care Alliance. This initiative is designed to enhance access to innovative imaging services and to foster a more integrated and coordinated experience for both clinicians and patients within the Sutter Health network. The collaboration aims to expand access to vital diagnostic care throughout California, equipping patients with advanced technology in their local communities. This will facilitate quicker appointment scheduling, faster diagnostic imaging results, earlier diagnoses, increased convenience, and more consistent and timely care. This Care Alliance represents one of the largest enterprise strategic partnerships ever established by GE HealthCare.

Key Players Operating in United States Specialty PACS Market are:

  • IBM Corporation
  • Mckesson Corporation
  • Agfa US Corp.
  • Onex Corporation (Carestream Health, Inc.)
  • Novarad Corporation
  • Intelerad Medical Systems Incorporated
  • INFINITT Healthcare Co., Ltd.
  • Sectra Medical, Inc.
  • Topcon Corporation
  • Meddiff Technologies Private Limited

If you can't find what you're searching for or have any custom requirements for the United States specialty PACS market, you may approach our team at info@marketsandata.com.

Frequently Asked Questions

What are the regions covered in the final report for the United States specialty PACS market?

arrowup
Heart

Global HIV Drugs Market Assessment, Opportunities and Forecast, 2018-2032F

The market’s growth can be attributed to the rising prevalence of HIV infections, introduction of strategic partnerships and collaborations, and growing awareness among the general population.....Read More

Published on

May 2025

4,500

Heart

Global Multiple Myeloma Market Assessment, Opportunities and Forecast, 2018-2032F

The growth of the market is supported by the rising prevalence of hematological cancer, growing healthcare infrastructure and increasing geriatric population, and rapidly growing government support.....Read More

Published on

May 2025

4,500

Heart

Global Acute Care Telemedicine Market Assessment, Opportunities and Forecast, 2018-2032F

The market’s growth can be attributed to the rising cases of chronic diseases, increasing focus on innovation, and introduction of supportive government initiatives.....Read More

Published on

May 2025

4,500

Heart

Global Antibody Drug Conjugates Market Assessment, Opportunities and Forecast, 2018-2032F

The growth of the market is supported by the growing demand for fast pacing therapeutic development, technological advancements in the biotechnology sector, rising burden of chronic diseases, and rapidly growing government support.....Read More

Published on

May 2025

4,500

Purchase Options

USD ($)

arrowdown

i

1,840

2,000

8%

i

2,970

3,300

10%

i

3,960

4,500

12%

i

5,950

7,000

15%

Tired of Searching?

Looking for Customization?

Some other doubt?

Need insights from a cohort?

REACH US

    icon_Five
    1st Floor, JDKD Corporate, A-23, Mathura Rd, Near Sarita Vihar Metro Station, Mohan Cooperative Industrial Estate, Saidabad, New Delhi -110044
icon_Seven
5741 Cleveland street, Suite 120, VA beach, VA, USA 23462
icon_Eight
190 Middle Road, # 14-10 Fortune Centre, Singapore -188979